Search PubMed⌕ Search

Biomedical subjects

J W Anderson

Publications and source records attributed to J W Anderson.

At least 55 records · Page 3Linked to original sources
PubMed2000

Whole grain foods and heart disease risk.

Coronary heart disease (CHD) is the leading cause of death in most developed nations and is rapidly increasing in prevalence in developing countries. Death rates from cardiovascular disease exceed 1 million annually in the United States and account for the largest disease-related cost to health with total costs estimated to exceed $120 billion per annum. Many dietary factors, including total and saturated fat consumption, fruit and vegetable intake and dietary fiber, have been shown to contribute to risk for CHD. We have systematically reviewed literature from the past 20 years evaluating an association between dietary fiber and CHD. Foods that are rich in dietary fiber, including fruits, vegetables, legumes and whole grain cereals, also tend to be a rich source of vitamins, minerals, phytochemicals. antioxidants and other micronutrients. Each of these factors may be independently contributing to the cardiovascular protective effects of fiber-rich foods.

Coronary Disease↗
PubMed2000

Cholesterol-lowering effects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials.

BACKGROUND: Soluble fibers, including those from psyllium husk, have been shown to augment the cholesterol-lowering effects of a low-fat diet in persons with hypercholesterolemia. As evidence of this, the US Food and Drug Administration recently authorized the use of health claims on food products containing soluble fiber from psyllium that state that they are associated with a decreased risk of coronary heart disease. OBJECTIVE: This meta-analysis was conducted to more precisely define the hypolipidemic effects and safety of psyllium when used adjunctive to a low-fat diet in men and women with hypercholesterolemia. DESIGN: The 8 studies in the meta-analysis included a total of 384 and 272 subjects receiving psyllium or cellulose placebo, respectively. All studies evaluated the hypocholesterolemic effects of 10.2 g psyllium/d adjunctive to a low-fat diet for >/=8 wk in individuals with mild-to-moderate hypercholesterolemia after a low-fat diet lead-in phase lasting >/=8 wk. The safety and adverse events associated with psyllium consumption were summarized from pooled data of 19 clinical studies ranging from 6 wk to 6 mo in duration. RESULTS: Consumption of 10.2 g psyllium/d lowered serum total cholesterol by 4% (P < 0.0001), LDL cholesterol by 7% (P < 0.0001), and the ratio of apolipoprotein (apo) B to apo A-I by 6% (P < 0.05) relative to placebo in subjects already consuming a low-fat diet, with no effect on serum HDL or triacylglycerol concentrations. CONCLUSIONS: Psyllium supplementation significantly lowered serum total and LDL-cholesterol concentrations in subjects consuming a low-fat diet. Psyllium is well tolerated and safe when used adjunctive to a low-fat diet in individuals with mild-to-moderate hypercholesterolemia.

Adult↗
PubMed2000

Long-term cholesterol-lowering effects of psyllium as an adjunct to diet therapy in the treatment of hypercholesterolemia.

BACKGROUND: Hypercholesterolemia is a major risk factor for coronary heart disease and nutrition management is the initial therapeutic approach. OBJECTIVE: This multicenter study evaluated the long-term effectiveness of psyllium husk fiber as an adjunct to diet in the treatment of persons with primary hypercholesterolemia. DESIGN: Men and women with hypercholesterolemia were recruited. After following an American Heart Association Step I diet for 8 wk (dietary adaptation phase), eligible subjects with serum LDL-cholesterol concentrations between 3.36 and 4.91 mmol/L were randomly assigned to receive either 5.1 g psyllium or a cellulose placebo twice daily for 26 wk while continuing diet therapy. RESULTS: Serum total and LDL-cholesterol concentrations were 4.7% and 6.7% lower in the psyllium group than in the placebo group after 24-26 wk (P < 0.001). Other outcome measures did not differ significantly between groups. CONCLUSIONS: Treatment with 5.1 g psyllium twice daily produces significant net reductions in serum total and LDL-cholesterol concentrations in men and women with primary hypercholesterolemia. Psyllium therapy is an effective adjunct to diet therapy and may provide an alternative to drug therapy for some patients.

Adult↗
PubMed2000

Serum immunoglobulin G and M concentrations did not appear to be associated with resistance to Pasteurella multocida in a large-bodied turkey line and a randombred control population.

Serum IgG and IgM concentrations in a randombred control line (RBC2) of turkeys and its subline (F), selected long term for increased 16-wk BW were compared. Six-week-old poults were challenged with virulent Pasteurella multocida (1.2 x 10(7) bacteria per bird of serogroup A and serotype 3,4). Sera were collected prior to challenge, and concentrations of IgG and IgM in turkey sera were quantitatively estimated with a Sandwich ELISA using the cross-reactive polyclonal antibodies specific for the chicken Ig isotypes. The F-line turkeys had a higher serum IgM concentration than turkeys from the RBC2 line. There was no significant line difference in IgG concentration. The F line had higher mortality and a shorter number of days to death following challenge with P. multocida than did the RBC2 line. No significant correlation coefficient was found between immunoglobulin isotype concentration in serum and days to death following challenge with P. multocida. The present results suggested that prechallenge IgG and IgM concentrations in serum did not appear to be associated with resistance to P. multocida in a large-bodied turkey line and a randombred control population.

Animal Husbandry↗
PubMed2000

Genetics of growth and reproduction in the turkey. 14. Changes in genetic parameters over thirty generations of selection for increased body weight.

A line (F) of turkeys was selected over 30 generations for increased 16-wk BW. The base population for the F line was a randombred control population (RBC2) that was maintained without conscious selection and used to remove yearly environmental variation in the F line. Selection was effective in increasing 16-wk BW in the F line. Selection differentials based on the mean of selected parents minus mean of entire population (intended) and intended selection differentials weighted for number of offspring produced (actual) did not consistently differ, indicating that natural selection was not significantly opposing artificial selection. The realized heritability (h2) of 16-wk BW in the F line, based on the linear regression of the selection response on accumulated actual selection differentials, declined with selection; the decline appeared to be slightly different for males than females. For both sexes combined, the realized h2 was 0.309+/-0.022 (SE), 0.268+/-0.033, 0.242+/-0.026, and 0.254+/-0.007, respectively, for Generations 1 to 10, 11 to 20, 21 to 30, and 1 to 30. Genetic increases in 16-wk BW in the F line were positively associated with BW at other ages (8, 20, and 24 wk of age and at 50% production), days from stimulatory lighting to production of the first egg, and egg weight. Genetic increases were negatively associated with egg production, intensity of lay (maximum and average clutch length and rate of lay), and hatch of fertile eggs. There was no significant relationship between 16-wk BW and total days lost from broodiness or fertility. The genetic changes in some correlated traits were not consistent in all generation intervals studied, indicating that the genetic correlation between the selected trait (16 wk BW) and the correlated trait changed with selection.

Animals↗
PubMed2000

Antibody responses to sheep red blood cell and Brucella abortus antigens in a turkey line selected for increased body weight and its randombred control.

Turkeys from a randombred control line (RBC2) and its subline (F) selected for increased 16-wk BW were tested for primary and secondary antibody responses to SRBC antigen and Brucella abortus antigen (BA). Previous studies have shown that the F line was more susceptible to Pasteurella multocida and Newcastle disease virus than was the RBC2 line. Individuals from the RBC2 and F lines were intravenously injected with 1 mL 5% SRBC antigen or 0.1 mL undiluted BA at 4 and 6 wk of age; blood samples were collected at 0, 4, 7, and 10 d post-immunization. Total, IgG, and IgM titers were measured by agglutination assays. Compared with the RBC2 line, the F line had generally higher total anti-SRBC titers; the differences were significant at 14 d postprimary immunization (PPI) (females); at 10 d postsecondary immunization (PSI) (males); and 4, 7, and 10 d PSI (females) (P < or = 0.05). The F line also had higher IgM titers at 14 d PPI (females) and at 10 d PSI (males) (P < or = 0.05). For IgG titers, a line difference was evident in females at 4 and 10 d PSI (P < or = 0.05); the F line had higher titers than did the RBC2 line. For the antibody response to BA in males, the F line had lower total and IgM titers at 10 d PPI (P < 0.05) than did the RBC2 line. No significant line differences in response to the BA were found in total and IgM titers in female turkeys or in IgG titers in both sexes at any time. These results suggest that selection for fast growth rate of turkeys might have resulted in changes in humoral immunity to the SRBC antigen and BA.

Animals↗
PubMed2000

Effects of selection for increased body weight, egg production, and shank width on developmental stability in turkeys.

Bilateral asymmetry was measured at 20 wk of age for shank length, shank width (width laterally at the dew claw), shank depth (width perpendicular to the dew claw), and face length (between auditory canal opening and the posterior junction of the upper and lower mandible) in three randombred control lines and three selected lines of turkeys. The data were based on 50 or 51 individuals per line and sex subgroup from a single hatch. The lines were grown intermingled with the sexes being grown in different houses. The selected lines had been selected for increased egg production (38 generations), increased 16-wk BW (32 generations), or increased shank width (19 generations) and had a higher level of inbreeding (average = 36.9%) than the randombred controls (RBC; average = 11.6%). The bilateral differences (right minus left) were analyzed for the presence of fluctuating asymmetry (FA; zero signed mean with normal variation), directional asymmetry (DA; signed mean not zero with normal variation), and antisymmetry (AS; zero mean with non-normal distribution). In order to adjust for possible scaling effects, relative asymmetry (RA), in which the mean of the absolute differences between sides was divided by the mean of the two sides and the resulting value was multiplied by 100, was used as a measure of bilateral asymmetry. The randombred control and selected lines were contrasted to study the effect of homozygosity on RA. Likewise, the large-bodied lines (F, FL, and RBC3) were contrasted to the small-bodied lines (RBC1, E, and RBC2) to study the effect of BW on RA. Only two types (FA and DA) of asymmetry were observed in the present study. The level of asymmetry for the traits was ranked as follows: face length > shank width = shank depth > shank length. The individual lines differed in RA for shank length and shank width for both sexes and for shank depth and face length in females. In general, the influence of BW, as measured in the contrast of large-bodied and small-bodied lines, on RA was larger than that of homozygosity, as measured by the contrast of the selected and randombred control lines.

Animals↗
PubMed1999

Age-related changes in quantitative EEG in attention-deficit/hyperactivity disorder.

BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) in children and adolescents is characterized by excessive restlessness and an extremely poor concentration span, resulting in impulsive and disruptive behavior. Clinical observation of ADHD in adults suggests that the hyperactivity component is diminished although the impulsive type behaviors remain apparent. EEG studies of children and adolescents with ADHD have reported significantly higher levels of low frequency activity (predominantly theta) and lower levels of beta activity than normal controls. METHODS: We examined the relationship between the age-related changes reported in clinical observation and changes in EEG activity occurring in a group of ADHD patients ranging in age from 6 to 42 years. Quantitative EEGs were obtained from the midline sites of 25 children, 25 adolescents and 25 adults diagnosed with ADHD, and compared with those of age matched normal controls. RESULTS: Theta activity was elevated in the ADHD groups across all age groups compared with the normal controls. The extent of the reduction in relative beta activity in the ADHD groups compared to normal controls decreased with increasing age. CONCLUSIONS: Given that the hyperactivity component in ADHD reduces with age while the impulsivity component remains, these data, in ADHD, suggest that decreased beta activity may be linked to hyperactivity and increased theta activity to impulsivity.

Adolescent↗
PubMed1999

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group.

BACKGROUND: Although it is generally accepted that lowering elevated serum levels of low-density lipoprotein (LDL) cholesterol in patients with coronary heart disease is beneficial, there are few data to guide decisions about therapy for patients whose primary lipid abnormality is a low level of high-density lipoprotein (HDL) cholesterol. METHODS: We conducted a double-blind trial comparing gemfibrozil (1200 mg per day) with placebo in 2531 men with coronary heart disease, an HDL cholesterol level of 40 mg per deciliter (1.0 mmol per liter) or less, and an LDL cholesterol level of 140 mg per deciliter (3.6 mmol per liter) or less. The primary study outcome was nonfatal myocardial infarction or death from coronary causes. RESULTS: The median follow-up was 5.1 years. At one year, the mean HDL cholesterol level was 6 percent higher, the mean triglyceride level was 31 percent lower, and the mean total cholesterol level was 4 percent lower in the gemfibrozil group than in the placebo group. LDL cholesterol levels did not differ significantly between the groups. A primary event occurred in 275 of the 1267 patients assigned to placebo (21.7 percent) and in 219 of the 1264 patients assigned to gemfibrozil (17.3 percent). The overall reduction in the risk of an event was 4.4 percentage points, and the reduction in relative risk was 22 percent (95 percent confidence interval, 7 to 35 percent; P=0.006). We observed a 24 percent reduction in the combined outcome of death from coronary heart disease, nonfatal myocardial infarction, and stroke (P< 0.001). There were no significant differences in the rates of coronary revascularization, hospitalization for unstable angina, death from any cause, and cancer. CONCLUSIONS: Gemfibrozil therapy resulted in a significant reduction in the risk of major cardiovascular events in patients with coronary disease whose primary lipid abnormality was a low HDL cholesterol level. The findings suggest that the rate of coronary events is reduced by raising HDL cholesterol levels and lowering levels of triglycerides without lowering LDL cholesterol levels.

Aged↗
PubMed1999

Postprandial low-density lipoproteins in type 2 diabetes are oxidized more extensively than fasting diabetes and control samples.

This study examined the kinetics of low-density lipoprotein (LDL) oxidation in the fasting and postprandial states of diabetic and control subjects to determine if LDL oxidation may contribute to accelerated atherosclerosis in diabetes. We compared in vitro oxidation of LDL from 12 control and 13 Type 2 diabetic subjects in the fasting and postprandial states. The extent of oxidation was assessed by length of lag phase, formation of conjugated dienes (CD), lipid peroxides, thiobarbituric acid reactive substances (TBARS), and percentage reduction in free amine groups. Diabetic subjects were significantly older and heavier. Comparisons between control and diabetic subjects in the postprandial state showed that the lag phase was significantly shorter in diabetic subjects than controls (P = 0.005), TBARS were significantly higher (P = 0.006), and levels of CD were higher at 60, 65, and 70 min (P < 0.01). In the fasting state, however, these comparisons were not significant. In diabetic subjects, postprandial samples had a significantly shorter lag phase (P = 0.003), higher TBARS (P = 0.006), and higher levels of CD at 60, 65 (P < 0.001), and 70 min (P = 0.0013) compared to fasting samples. Elevated levels of serum triglycerides in diabetic subjects were negatively correlated to lag phase, in fasting (P = 0.06) and postprandial states (P = 0.002). We conclude that accelerated oxidation of LDL seen in postprandial states in diabetes may be a critical contributor to cardiovascular risks. Elevated levels of serum triglycerides may contribute to the rapid oxidation of LDL seen in diabetic subjects.

Adult↗
PubMed1999

Effect of fermented milk (yogurt) containing Lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemic humans.

OBJECTIVE: Two controlled clinical studies were performed to examine effects of consumption of one daily serving of fermented milk (FM) (yogurt) on serum lipids. METHODS: In the first study, subjects were randomly allocated to FM containing Lactobacillus acidophilus L1 of human origin or to FM containing L. acidophilus ATCC 43211 of swine origin. In this single-blind study, subjects consumed one 200 ml serving of FM daily for 3 weeks. The second study was a double-blind, placebo-controlled, cross-over study. Subjects completed a 4-week first treatment, had a 2-week washout, and completed a second 4-week treatment. In the second study subjects consumed FM containing L. acidophilus L1 or placebo FM over 4 weeks. RESULTS: In the first study, FM containing L. acidophilus L1 was accompanied by a 2.4% (p<0.05) reduction of serum cholesterol concentration. In the second study, strain L1 reduced serum cholesterol concentration by 3.2% (p<0.05) in the first treatment period. In the second treatment period there were no significant changes in serum cholesterol concentration. Combined analysis of the two L1 treatment studies demonstrated a 2.9% (p<0.01) reduction in serum cholesterol concentration. CONCLUSION: Since every 1% reduction in serum cholesterol concentration is associated with an estimated 2% to 3% reduction in risk for coronary heart disease, regular intake of FM containing an appropriate strain of L. acidophilus has the potential of reducing risk for coronary heart disease by 6 to 10%.

Analysis of Variance↗
PubMed1999

Antioxidant supplementation effects on low-density lipoprotein oxidation for individuals with type 2 diabetes mellitus.

OBJECTIVE: This study compared susceptibility to oxidation of low-density lipoproteins (LDL) of non-diabetic and diabetic (Type 2) men and examined the response of diabetic men to antioxidant supplementation (alpha-tocopherol, beta-carotene and ascorbate). RESEARCH DESIGN AND METHODS: Twenty adult non-diabetic and 20 diabetic men were recruited. Oxidation of LDL was assessed by four different assay systems, and the extent of oxidation was assessed by four different measurements. Diabetic men received eight weeks of placebo ("baseline"), twelve weeks of antioxidant supplements ("treated") and eight weeks of placebo ("post-treatment"). Supplements provided 24 mg of beta-carotene, 1000 mg of ascorbate and 800 IU of alpha-tocopherol daily. RESULTS: With Cu oxidation at 37 degrees C, thiobarbituric reactive substances (TBARS) formation was significantly higher (p=0.032) and loss of free amine groups was significantly greater (p=0.013) in the LDL from diabetic subjects than controls. Antioxidant supplementation of diabetic subjects significantly decreased all parameters of LDL oxidation with Cu at 30 degrees C and 37 degrees C. At 30 degrees C the lag phase increased from 55 to 129 minutes (p<0.0001); conjugated diene formation decreased from 1.23 to 0.62 OD units (p<0.0001); TBARS formation decreased from 78 to 33 nmoles MDA/mg LDL protein (p<0.0001); and free amine loss decreased from 41 to 12% (p<0.0001). With Cu oxidation at 37 degrees C, similar changes occurred. CONCLUSIONS: These studies indicate that the LDL from diabetic subjects are more susceptible to oxidation than LDL from non-diabetic subjects. Supplementation of diabetic subjects with antioxidant vitamins significantly decreases susceptibility of LDL to oxidation by Cu. These studies are consistent with epidemiological and intervention studies suggesting that antioxidant vitamin use significantly decreases risk for coronary heart disease.

Adult↗
PubMed1999

Long-term weight maintenance after an intensive weight-loss program.

OBJECTIVE: This prospective study assessed long-term weight maintenance of patients completing an intensive very-low-calorie diet (VLCD) weight-loss program. SUBJECTS: Individuals who had completed the 12-week core education program and lost > or = 10 kg were recruited. RESULTS: Of 154 eligible subjects, follow-up weights were obtained at > or = 2 years in 112 subjects (72.7%, 72 women, 40 men). Subjects had an average initial body mass index of 37.3 kg/m2 and an average weight loss of 29.7 kg in five months. Six hundred and forty-five follow-up weights (median, five per subject) were obtained over two to seven years of follow-up from clinic visits (70%) and self-report by telephone or mail (30%). Subjects regained an average of 2.5% per month of their lost weight during the first two to three years of follow-up; however, their weight stabilized over the next four years. Subjects regained an average of 73.4% of their weight loss during the first three years. The average weight loss maintained for 112 subjects was 22.8% of initial weight loss after an average of 5.3 years of follow-up. When successful weight maintenance was defined as maintaining a weight loss of 5% or 10% of initial (pre-treatment) body weight, 40% were maintaining a 5% weight loss at five years and 25% were maintaining a weight loss of 10% at 7 years. Multiple regression analyses suggested that age had a significant (p=0.004) and positive effect on weight maintenance. CONCLUSIONS: This study suggests that weight maintenance after an intensive VLCD program is improving but still needs intensive efforts to enable most individuals to maintain a substantial percentage of their weight loss long-term.

Adult↗
PubMed1999

Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study.

BACKGROUND: Long-term maintenance of weight loss remains a therapeutic challenge in obesity treatment. OBJECTIVE: This multicenter, double-blind, placebo-controlled study was designed to test the hypothesis that orlistat, a gastrointestinal lipase inhibitor, is significantly more effective than a placebo in preventing weight regain. DESIGN: Obese subjects who lost > or = 8% of their initial body weight during a 6-mo lead-in of a prescribed hypoenergetic diet (4180-kJ/d deficit) with no adjunctive pharmacotherapy were randomly assigned to receive placebo, 30 mg orlistat, 60 mg orlistat, or 120 mg orlistat 3 times daily for 1 y in combination with a maintenance diet to help prevent weight regain. Of 1313 recruited subjects [body mass index (in kg/m2): 28-43], 729 subjects lost > or =8% of their initial body weight during the 6-mo weight-loss lead-in period and were enrolled in the double-blind phase. RESULTS: After 1 y, subjects treated with 120 mg orlistat 3 times daily regained less weight than did placebo-treated subjects (32.8 +/- 4.5% compared with 58.7 +/- 5.8% regain of lost weight; P < 0.001). Moreover, more subjects in the 120-mg orlistat group than in the placebo group regained < or = 25% of lost weight (47.5% of subjects compared with 29.9%). In addition, orlistat treatment (120 mg 3 times daily) was associated with significantly greater reductions in total and LDL-cholesterol concentrations than was placebo (P < 0.001). CONCLUSION: The use of orlistat during periods of attempted weight maintenance minimizes weight readjustment and facilitates long-term improvement in obesity-related disease risk factors.

Adult↗
PubMed1999

Cardiovascular and renal benefits of dry bean and soybean intake.

Dry beans and soybeans are nutrient-dense, fiber-rich, and are high-quality sources of protein. Protective and therapeutic effects of both dry bean and soybean intake have been documented. Studies show that dry bean intake has the potential to decrease serum cholesterol concentrations, improve many aspects of the diabetic state, and provide metabolic benefits that aid in weight control. Soybeans are a unique source of the isoflavones genistein and diadzein, which have numerous biological functions. Soybeans and soyfoods potentially have multifaceted health-promoting effects, including cholesterol reduction, improved vascular health, preserved bone mineral density, and reduction of menopausal symptoms. Soy appears to have salutary effects on renal function, although these effects are not well understood. Whereas populations consuming high intakes of soy have lower prevalences of certain cancers, definitive experimental data are insufficient to clarify a protective role of soy. The availability of legume products and resources is increasing, incorporating dry beans and soyfoods into the diet can be practical and enjoyable. With the shift toward a more plant-based diet, dry beans and soy will be potent tools in the treatment and prevention of chronic disease.

Antioxidants↗
PubMed1999

Effects of psyllium on glucose and serum lipid responses in men with type 2 diabetes and hypercholesterolemia.

BACKGROUND: Water-soluble dietary fibers decrease postprandial glucose concentrations and decrease serum cholesterol concentrations. This study examined the effects of administering psyllium to men with type 2 diabetes. OBJECTIVE: The objective was to evaluate the safety and effectiveness of psyllium husk fiber used adjunctively to a traditional diet for diabetes in the treatment of men with type 2 diabetes and mild-to-moderate hypercholesterolemia. DESIGN: After a 2-wk dietary stabilization phase, 34 men with type 2 diabetes and mild-to-moderate hypercholesterolemia were randomly assigned to receive 5.1 g psyllium or cellulose placebo twice daily for 8 wk. Serum lipid and glycemic indexes were evaluated biweekly on an outpatient basis and at weeks 0 and 8 in a metabolic ward. RESULTS: In the metabolic ward, the psyllium group showed significant improvements in glucose and lipid values compared with the placebo group. Serum total and LDL-cholesterol concentrations were 8.9% (P < 0.05) and 13.0% (P = 0.07) lower, respectively, in the psyllium than in the placebo group. All-day and postlunch postprandial glucose concentrations were 11.0% (P < 0.05) and 19.2% (P < 0.01) lower in the psyllium than in the placebo group. Both products were well tolerated, with no serious adverse events related to treatment reported in either group. CONCLUSION: The addition of psyllium to a traditional diet for persons with diabetes is safe, is well tolerated, and improves glycemic and lipid control in men with type 2 diabetes and hypercholesterolemia.

Adult↗